BPC-157 is a research-stage compound with promising preclinical data but limited human clinical evidence
"These drugs are thought to work by engaging part of the brain called the hypothalamus, which helps regulate a wide variety of hormones," says Jena Shaw Tronieri, Senior Research Investigator at Penn's Center for Weight and Eating Disorders and a co-author of the study
Active or suspected cancer GHK-Cu has complex effects on cancer biology that remain incompletely understood
Palacka, P., Kucharska, J., Murin, J., Dostalova, K., Okkelova, A., Cizova, M., Waczulikova, I., Moricova, S., and Gvozdjakova, A
The AAPS journal, 17(1), 134143